Perimeter Medical Imaging AI (PYNKF) Corporate Presentation from NobleCon18News and Market Data on Perimeter Medical Imaging AINobleCon 18 Complete Rebroadcast |
Access to Exclusive Content. FREE for Registered Users Only.
Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost.
Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
Don't have an account? Join
Forgot passwordBy clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.
Related News
12/19/2024
Natural Resources
Agnico Eagle to Acquire O3 Mining in Strategic $204 Million Transaction
Agnico Eagle Mines Limited has announced a definitive agreement to acquire O3 Mining Inc., a gold exploration and development company based in Québec, Canada. This $204 million all-cash transaction marks...
3 min read
12/19/2024
Consumer
Tripadvisor and Liberty TripAdvisor Announce Merger to Simplify Corporate Structure
Tripadvisor, Inc. (NASDAQ: TRIP) and Liberty TripAdvisor Holdings, Inc. (OTCMKTS: LTRPA, LTRPB) have announced a definitive agreement to merge. The merger will see Tripadvisor acquiring Liberty TripAdvisor, resulting in a...
3 min read
12/19/2024
Health
Release – Data and Safety Monitoring Board Reviews Interim Safety Data of Phase 2 Subjects of OCU410 ArMaDa Clinical Trial for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that the Data...
6 min read
12/18/2024
Healthcare
Cara Therapeutics and Tvardi Therapeutics to Merge, Forming New Biopharma Leader
Cara Therapeutics (Nasdaq: CARA) and Tvardi Therapeutics have announced a definitive merger agreement, marking a significant step in the development of innovative treatments for fibrosis-driven diseases. The all-stock transaction will...
3 min read
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.